03/14/23 4:05 PMNasdaq : BLACU acquisitionlow floatBellevue Life Sciences Acquisition Corp. Announces Separate Trading of its Shares of Common Stock, Warrants and Rights Commencing March 17, 2023Bellevue Life Sciences Acquisition Corp. announced that holders of the 6,900,000 units sold in the Company's initial public offering, including the 900,000 units sold pursuant to the full exercise of the underwriters' over-allotment option, may elect to separately trade the shares of common stock, warrants and rights included in the units commencing...RHEA-AIneutral
02/21/23 4:05 PMNasdaq : BLACU acquisitionlow floatBellevue Life Sciences Acquisition Corp. Announces Closing of Full Over-allotment OptionBellevue Life Sciences Acquisition Corp. today announced the closing of the over-allotment option that the Company granted to the underwriters of its initial public offering. The representative of the underwriters exercised the over-allotment option in full on February 17, 2023 and purchased an additional 900,000 units at the public offering price of...RHEA-AIneutral
02/14/23 4:05 PMNasdaq : BLACU IPOofferingacquisitionlow floatBellevue Life Sciences Acquisition Corp. Announces Closing of $60 Million Initial Public OfferingBellevue Life Sciences Acquisition Corp., a newly organized blank check company incorporated in Delaware, today announced that it closed its initial public offering of 6,000,000 units at a price of $10.00 per unit. After the securities comprising the units begin separate trading, the shares of common stock, warrants and rights are expected to be listed on...RHEA-AIneutral
